NASDAQ: MBX
Mbx Biosciences Inc Earnings Dates, Reports, Calls

Mbx Biosciences earnings were -$80.5M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest MBX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$21.6M, up 11.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MBX reported annual earnings of -$61.9M, with 90.2% growth.

MBX earnings history

Current Revenue
$0.0
Current Earnings
-$80.5M
Current Profit Margin
0%

MBX Return on Equity

Current Company
-29.3%
Current Industry
-20.2%
Current Market
32.1%
MBX's Return on Equity (-29.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MBX undefined

Current Company
-28.1%
Current Industry
-8.1%
MBX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MBX announces earnings.

MBX undefined

Current Company
-20.75%
Current Industry
-2.4%

MBX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MBX-$80.12M-$80.50MN/A$7.68
URGN-$144.14M-$164.64MN/A-$3.26
MNMD-$163.23M-$168.10MN/A-$1.97
ABCL-$170.12M-$171.68MN/A-$0.57
TNGX-$94.03M-$100.52MN/A-$0.91

Mbx Biosciences Earnings Reports & History FAQ

What were Mbx Biosciences's earnings last quarter?

On MBX's earnings call on Invalid Date, Mbx Biosciences (NASDAQ: MBX) reported Q3 2025 earnings per share (EPS) of -$0.63, up 77.34% year over year. Total MBX earnings for the quarter were -$21.62 million. In the same quarter last year, Mbx Biosciences's earnings per share (EPS) was -$2.78.

If you're new to stock investing, here's how to buy Mbx Biosciences stock.

Is Mbx Biosciences profitable or losing money?

As of the last Mbx Biosciences earnings report, Mbx Biosciences is currently losing money. Mbx Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$80.50 million, a 45.88% increase year over year.

What was MBX's earnings growth in the past year?

As of Mbx Biosciences's earnings date in Invalid Date, Mbx Biosciences's earnings has grown year over year. MBX earnings in the past year totalled -$80.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.